SpliceBio has closed a Series B financing round, raising $135m for the clinical development of SB-007 for Stargardt disease.

For decades, the dominant treatment approaches for substance use disorder have centered around identifying past deficits and unpacking trauma. SFT offers a compelling alternative.

Since the approval of Luxturna, there has been a wave of gene therapies advancing in clinical trials to treat genetic vision ...

This course provides a comprehensive introduction to computer vision. Major topics include image processing, detection and recognition, geometry-based and physics-based vision and video analysis.

With a focus on cutting-edge vision therapy, progressive myopia management and full-scope comprehensive eye care, a new name ...

Novo Nordisk's (NVO) weight loss drug semaglutide (Ozempic, Wegovy, Rybelsus) is linked to a rare eye condition called NAION ...

For people diagnosed with macular telangiectasia type 2 (MacTel)—a rare and slowly progressing retinal disease—there have ...

Aside from enjoying rest and relaxation, beachgoers will also be reaping the mental-health benefits of “sea therapy.” Thea Gallagher, PsyD, clinical associate professor of psychiatry at NYU ...

In this multicenter randomized controlled trial, a 12-week personalized visual perceptual learning (VPL) program significantly improved visual field function in stroke patients with visual field ...

CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 2030 Media Contact: Ned Berkowitz + 1 914-629-5157 Ned.Berkowitz ...

In short, these barriers cost lives," said Anna Sureda, MD, PhD, Clinical Hematologist, Professor and Cell Therapy Researcher; and Co-Chair, CAR T Vision Steering Committee. "We call on every ...